Valuation: AstraZeneca PLC

Market Cap 292B 256B 236B 219B 415B 27,860B 421B 2,820B 1,098B 13,676B 1,097B 1,073B 47,415B P/E 2026 *
23.5x
P/E 2027 * 20.7x
Enterprise Value 311B 273B 251B 233B 443B 29,697B 449B 3,006B 1,170B 14,577B 1,169B 1,143B 50,540B EV / Sales 2026 *
4.92x
EV / Sales 2027 * 4.54x
Free-Float
96.63%
Yield 2026 *
1.77%
Yield 2027 * 1.87%

Last Transcript: AstraZeneca PLC

1 day-2.93%
1 week-1.38%
1 month+2.20%
3 months-5.74%
6 months+0.44%
Current year+2.25%
1 week 13,838
Extreme 13838
14,686
1 month 11,364
Extreme 11364
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,148
Extreme 10148
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
May. 13Fiscal year

Chief Executive Officer

18,359 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-2.46%-1.38%+37.99%+36.52% 299B
-1.14%-2.43%+55.27%+159.07% 1,082B
-1.41%+0.32%+67.02%+60.48% 633B
-2.42%+0.18%+35.78%+85.62% 461B
-2.79%+1.37%+31.00%+23.05% 338B
-2.20%-0.93%+27.50%+40.62% 291B
-1.77%+0.99%-28.85%-41.41% 222B
-2.06%+1.63%+25.09%+64.34% 202B
-1.26%+2.60%+15.95%+70.00% 163B
-2.47%-2.67%-6.02%-33.43% 139B
Average -2.01%+4.28%+26.07%+46.49% 383.1B
Weighted average by Cap. -1.74%+5.33%+38.91%+76.00%

Financials

2026 *2027 *
Net sales 63.26B 55.4B 51.03B 47.37B 89.94B 6,034B 91.16B 611B 238B 2,962B 238B 232B 10,269B 66.91B 58.6B 53.97B 50.1B 95.13B 6,382B 96.42B 646B 251B 3,133B 251B 246B 10,862B
Net income 12.46B 10.92B 10.05B 9.33B 17.72B 1,189B 17.96B 120B 46.84B 584B 46.81B 45.78B 2,023B 13.97B 12.23B 11.27B 10.46B 19.86B 1,332B 20.13B 135B 52.49B 654B 52.45B 51.3B 2,268B
Net Debt 19.25B 16.86B 15.53B 14.41B 27.37B 1,836B 27.74B 186B 72.34B 901B 72.29B 70.7B 3,125B 11.76B 10.3B 9.48B 8.8B 16.72B 1,121B 16.94B 114B 44.18B 550B 44.15B 43.18B 1,908B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-06 GBX 14,100.00 -2.46% 2,008,204
26-07-03 GBX 14,456.00 -0.56% 653,264
26-07-02 GBX 14,538.00 +4.94% 2,810,574
26-07-01 GBX 13,854.00 -1.74% 1,804,499
26-06-30 GBX 14,100.00 -1.38% 2,513,351
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
193.04USD
Average target price
217.23USD
Spread / Average Target
+12.53%

Quarterly revenue - Rate of surprise